We are live on ! Find out more
VIVO

Meridian Bioscience Inc

Delisted

VIVO was delisted on the 30th of January, 2023.

173 hedge funds and large institutions have $726M invested in Meridian Bioscience Inc in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 67 increasing their positions, 51 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 51

2% less capital invested

Capital invested by funds: $744M → $726M (-$17.9M)

4% less funds holding

Funds holding: 180173 (-7)

39% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 18

60% less call options, than puts

Call options by funds: $655K | Put options by funds: $1.62M

Holders
173
Holders Change
-7
Holders Change %
-3.89%
% of All Funds
4.62%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
67
Reduced
51
Closed
18
Calls
$655K
Puts
$1.62M
Net Calls
-$967K
Net Calls Change
-$274K
Name Holding Trade Value Shares
Change
Change in
Stake
Los Angeles Capital Management
76
Los Angeles Capital Management
California
$1.04M +$133K +6,810 +14%
GC
77
Guggenheim Capital
Illinois
$1.02M -$60.5K -3,089 -6%
TD Asset Management
78
TD Asset Management
Ontario, Canada
$970K +$389K +19,900 +65%
State of New Jersey Common Pension Fund D
79
State of New Jersey Common Pension Fund D
New Jersey
$965K
RA
80
Royce & Associates
New York
$932K
PC
81
Polar Capital
United Kingdom
$860K +$35.2K +1,800 +4%
State Board of Administration of Florida Retirement System
82
State Board of Administration of Florida Retirement System
Florida
$858K
HW
83
Hancock Whitney
Mississippi
$828K +$44.6K +2,279 +6%
Two Sigma Investments
84
Two Sigma Investments
New York
$827K -$146K -7,480 -15%
ACM
85
American Capital Management
New York
$820K +$832K +42,510 New
NA
86
Navellier & Associates
Nevada
$815K +$207K +10,601 +34%
Comerica Bank
87
Comerica Bank
Texas
$809K +$7.46K +381 +0.9%
NI
88
Numeric Investors
Massachusetts
$795K -$395K -20,200 -33%
Two Sigma Advisers
89
Two Sigma Advisers
New York
$751K +$180K +9,200 +31%
Legal & General Group
90
Legal & General Group
United Kingdom
$742K +$572K +29,250 +317%
CCMINC
91
Cardinal Capital Management Inc (North Carolina)
North Carolina
$731K +$71.8K +3,671 +11%
OSAM
92
O'Shaughnessy Asset Management
Connecticut
$704K +$313 +16 +0%
HCM
93
Hollencrest Capital Management
California
$683K
Wellington Management Group
94
Wellington Management Group
Massachusetts
$681K
ZCM
95
Zebra Capital Management
Connecticut
$672K +$103K +5,279 +18%
FIM
96
Freedom Investment Management
Connecticut
$658K +$54.6K +2,791 +9%
Royal Bank of Canada
97
Royal Bank of Canada
Ontario, Canada
$645K -$215K -11,005 -25%
State of Tennessee, Department of Treasury
98
State of Tennessee, Department of Treasury
Tennessee
$642K
MLICM
99
Metropolitan Life Insurance Company (MetLife)
New York
$633K
TPSF
100
Texas Permanent School Fund
Texas
$618K -$2.13K -109 -0.3%

VIVO Hedge Fund Activity: Q3 2016 in Review

173 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2016, worth a combined $726M — down 2.4% from $744M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of VIVO and 11 opened new positions — a net loss of 7 holders — while 51 trimmed existing stakes and 67 added.

The largest buyer was Prudential plc, adding an estimated $8.84M. The largest seller was Schroder Investment Management Group, cutting an estimated $10.1M.

  • 173 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2016, down from 180 in Q2 2016.
  • Funds reported $726M of Meridian Bioscience Inc stock for Q3 2016, down 2.4% quarter-over-quarter.
  • 11 funds opened new Meridian Bioscience Inc positions in Q3 2016 and 18 closed out, a net change of -7 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2016 was Prudential plc, an estimated $8.84M added.
  • The largest Meridian Bioscience Inc seller in Q3 2016 was Schroder Investment Management Group, an estimated $10.1M sold.

Based on aggregated 13F filings for Q3 2016.